Home » Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon announced Monday that it has entered into a definitive agreement to acquire Optonol, Ltd., a medical device company that develops, manufactures and
markets novel miniature surgical implants used to lower intraocular pressure in patients with glaucoma.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May